Drug Companies

16 of US's Top 17 Drug Companies Have Board Members Who Teach at Medical Hospitals

16 of US's Top 17 Drug Companies Have Board Members Who Teach at Medical Hospitals
Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals. A team of researchers examined the boards of the 50 largest drug companies and found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one.
origin Author: 
Charles Ornstein
origin Blog: 

As Full Disclosure Nears, Drug Companies Slash Speaking Fees for Doctors

As Full Disclosure Nears, Drug Companies Slash Speaking Fees for Doctors
Some of the nation’s largest pharmaceutical companies have slashed payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a new ProPublica analysis shows. Eli Lilly and Co.’s payments to speakers dropped by 55 percent, from $47.9 million in 2011 to $21.6 million in 2012. Pfizer’s speaking payments fell 62 percent over the same period, from nearly $22 million to $8.3 million.
origin Author: 
Charles Ornstein , Eric Sagara and Ryann Grochowski Jones
origin Blog: 

Dollars for Docs Mints a Millionaire

Dollars for Docs Mints a Millionaire
New data show drug makers’ payments to hundreds of thousands of doctors, and some have made well over $500,000.
origin Author: 
origin Blog: